IL-17 Production from Activated T Cells is Required for the Spontaneous Development of Destructive Arthritis in Mice Deficient in IL-1 Receptor Antagonist

Overview

Journal Proc Natl Acad Sci U S A

Specialty Science

Date 2003 May 2

PMID 12721360

Citations 212

Authors

Susumu Nakae

Shinobu Saijo

Reiko Horai

Katsuko Sudo

Shigeo Mori

Yoichiro Iwakura

Affiliations

Soon will be listed here.

Abstract

IL-17 is a T cell-derived, proinflammatory cytokine that is suspected to be involved in the development of various inflammatory diseases. Although there are elevated levels of IL-17 in synovial fluid of patients with rheumatoid arthritis, the pathogenic role of IL-17 in the development of rheumatoid arthritis remains to be elucidated. In this report, the effects of IL-17 deficiency were examined in IL-1 receptor antagonist-deficient (IL-1Ra(-/-)) mice that spontaneously develop an inflammatory and destructive arthritis due to unopposed excess IL-1 signaling. IL-17 expression is greatly enhanced in IL-1Ra(-/-) mice, suggesting that IL-17 activity is involved in the pathogenesis of arthritis in these mice. Indeed, the spontaneous development of arthritis did not occur in IL-1Ra(-/-) mice also deficient in IL-17. The proliferative response of ovalbumin-specific T cells from DO11.10 mice against ovalbumin cocultured with antigen-presenting cells from either IL-1Ra(-/-) mice or wild-type mice was reduced by IL-17 deficiency, indicating insufficient T cell activation. Cross-linking OX40, a cosignaling molecule on CD4(+) T cells that plays an important role in T cell antigen-presenting cell interaction, with anti-OX40 Ab accelerated the production of IL-17 induced by CD3 stimulation. Because OX40 is induced by IL-1 signaling, IL-17 induction is likely to be downstream of IL-1 through activation of OX40. These observations suggest that IL-17 plays a crucial role in T cell activation, downstream of IL-1, causing the development of autoimmune arthritis.

Citing Articles

The Role of IL-17 in Systemic Autoinflammatory Diseases: Mechanisms and Therapeutic Perspectives.

Zhang J, Shen M Clin Rev Allergy Immunol. 2025; 68(1):27.

PMID: 40074883 DOI: 10.1007/s12016-025-09042-5.

Models for T-large granular lymphocytic leukemia: how to mimic the cellular interplays in malignant autoimmunity.

Klepzig H, Herling M, Pflug N, Braun T Leukemia. 2025; .

PMID: 40055531 DOI: 10.1038/s41375-025-02553-2.

Osteoporosis and Rheumatoid Arthritis: Mechanisms Underlying Osteoclast Differentiation and Activation or Factors Associated with Hip Fractures.

Miyamoto T J Clin Med. 2025; 14(4).

PMID: 40004668 PMC: 11856638. DOI: 10.3390/jcm14041138.

Association of Serum IL-17 and IL-23 Cytokines With Disease Activity and Various Parameters of Rheumatoid Arthritis in Indian Patients.

Meher J, Patel S, Nanda R, Siddiqui M Cureus. 2024; 15(11):e49654.

PMID: 38161845 PMC: 10756251. DOI: 10.7759/cureus.49654.

Genomic repertoires linked with pathogenic potency of arthritogenic isolated from the gut of patients with rheumatoid arthritis.

Nii T, Maeda Y, Motooka D, Naito M, Matsumoto Y, Ogawa T Ann Rheum Dis. 2023; 82(5):621-629.

PMID: 36627170 PMC: 10176341. DOI: 10.1136/ard-2022-222881.

References

Horai R, Saijo S, Tanioka H, Nakae S, Sudo K, Okahara A . Development of chronic inflammatory arthropathy resembling rheumatoid arthritis in interleukin 1 receptor antagonist-deficient mice. J Exp Med. 2000; 191(2):313-20. PMC: 2195765. DOI: 10.1084/jem.191.2.313. View

Quach J, Lotz M . Interleukin-17-induced gene expression in articular chondrocytes is associated with activation of mitogen-activated protein kinases and NF-kappaB. J Biol Chem. 1998; 273(42):27467-73. DOI: 10.1074/jbc.273.42.27467. View

Schwarzenberger P, Huang W, Ye P, Oliver P, Manuel M, Zhang Z . Requirement of endogenous stem cell factor and granulocyte-colony-stimulating factor for IL-17-mediated granulopoiesis. J Immunol. 2000; 164(9):4783-9. DOI: 10.4049/jimmunol.164.9.4783. View

Albanesi C, Scarponi C, Cavani A, Federici M, Nasorri F, Girolomoni G . Interleukin-17 is produced by both Th1 and Th2 lymphocytes, and modulates interferon-gamma- and interleukin-4-induced activation of human keratinocytes. J Invest Dermatol. 2000; 115(1):81-7. DOI: 10.1046/j.1523-1747.2000.00041.x. View

Hirahara N, Nio Y, Sasaki S, Takamura M, Iguchi C, Dong M . Reduced invasiveness and metastasis of Chinese hamster ovary cells transfected with human interleukin-17 gene. Anticancer Res. 2000; 20(5A):3137-42. View

Yoshioka T, Nakajima A, Akiba H, Ishiwata T, Asano G, Yoshino S . Contribution of OX40/OX40 ligand interaction to the pathogenesis of rheumatoid arthritis. Eur J Immunol. 2000; 30(10):2815-23. DOI: 10.1002/1521-4141(200010)30:10<2815::AID-IMMU2815>3.0.CO;2-#. View

Nakae S, Asano M, Horai R, Sakaguchi N, Iwakura Y . IL-1 enhances T cell-dependent antibody production through induction of CD40 ligand and OX40 on T cells. J Immunol. 2001; 167(1):90-7. DOI: 10.4049/jimmunol.167.1.90. View

Lubberts E, Joosten L, Oppers B, van den Bersselaar L, Kolls J, Schwarzenberger P . IL-1-independent role of IL-17 in synovial inflammation and joint destruction during collagen-induced arthritis. J Immunol. 2001; 167(2):1004-13. DOI: 10.4049/jimmunol.167.2.1004. View

Higuchi T, Aiba Y, Nomura T, Matsuda J, Mochida K, Suzuki M . Cutting Edge: Ectopic expression of CD40 ligand on B cells induces lupus-like autoimmune disease. J Immunol. 2001; 168(1):9-12. DOI: 10.4049/jimmunol.168.1.9. View

10.

Saijo S, Asano M, Horai R, Yamamoto H, Iwakura Y . Suppression of autoimmune arthritis in interleukin-1-deficient mice in which T cell activation is impaired due to low levels of CD40 ligand and OX40 expression on T cells. Arthritis Rheum. 2002; 46(2):533-44. DOI: 10.1002/art.10172. View

11.

Weinberg A . OX40: targeted immunotherapy--implications for tempering autoimmunity and enhancing vaccines. Trends Immunol. 2002; 23(2):102-9. DOI: 10.1016/s1471-4906(01)02127-5. View

12.

Iwakura Y . Roles of IL-1 in the development of rheumatoid arthritis: consideration from mouse models. Cytokine Growth Factor Rev. 2002; 13(4-5):341-55. DOI: 10.1016/s1359-6101(02)00021-7. View

13.

Nakae S, Komiyama Y, Nambu A, Sudo K, Iwase M, Homma I . Antigen-specific T cell sensitization is impaired in IL-17-deficient mice, causing suppression of allergic cellular and humoral responses. Immunity. 2002; 17(3):375-87. DOI: 10.1016/s1074-7613(02)00391-6. View

14.

Mori S, Sawai T, Teshima T, KYOGOKU M . A new decalcifying technique for immunohistochemical studies of calcified tissue, especially applicable to cell surface marker demonstration. J Histochem Cytochem. 1988; 36(1):111-4. DOI: 10.1177/36.1.3275709. View

15.

Murphy K, Heimberger A, Loh D . Induction by antigen of intrathymic apoptosis of CD4+CD8+TCRlo thymocytes in vivo. Science. 1990; 250(4988):1720-3. DOI: 10.1126/science.2125367. View

16.

Durie F, Fava R, Foy T, Aruffo A, Ledbetter J, Noelle R . Prevention of collagen-induced arthritis with an antibody to gp39, the ligand for CD40. Science. 1993; 261(5126):1328-30. DOI: 10.1126/science.7689748. View

17.

Yellin M, Sippel K, Inghirami G, Covey L, Lee J, Sinning J . CD40 molecules induce down-modulation and endocytosis of T cell surface T cell-B cell activating molecule/CD40-L. Potential role in regulating helper effector function. J Immunol. 1994; 152(2):598-608. View

18.

Yao Z, Painter S, Fanslow W, Ulrich D, Macduff B, Spriggs M . Human IL-17: a novel cytokine derived from T cells. J Immunol. 1995; 155(12):5483-6. View

19.

Wagner U, Kurtin P, Wahner A, Brackertz M, Berry D, Goronzy J . The role of CD8+ CD40L+ T cells in the formation of germinal centers in rheumatoid synovitis. J Immunol. 1998; 161(11):6390-7. View

20.

Antonysamy M, Fanslow W, Fu F, Li W, Qian S, Troutt A . Evidence for a role of IL-17 in organ allograft rejection: IL-17 promotes the functional differentiation of dendritic cell progenitors. J Immunol. 1999; 162(1):577-84. View